Philip Siberg has replaced Pia Renaudin who has been the CEO of Senzime since February 2019.
Philip Siberg has been Chairman of Senzime since 2016, when the company acquired Acacia Designs, which he was the CEO of. Acacia Designs pioneered the development of the TetraGraph system based on research from Mayo Clinic in the USA, and it’s today Senzime’s main line of business.
Philip Siberg has solid experience from various CEO and chairman roles within the life science industry and especially commercialization of innovations in the US healthcare market. By the appointment, the board believes that Senzime has increased chances to succeed with the commercialization that has rapidly commenced in the US, and Siberg brings in deep insights into Senzime’s product offering, organization, and market.
“The company has a fantastic product portfolio, organization and market position which is now facing a powerful global growth journey,” says Philip Siberg.